BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26845117)

  • 1. Assessing the Impact of Postoperative Radiation Therapy for Completely Resected Limited-Stage Small Cell Lung Cancer Using the National Cancer Database.
    Wong AT; Rineer J; Schwartz D; Schreiber D
    J Thorac Oncol; 2016 Feb; 11(2):242-8. PubMed ID: 26845117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for Adjuvant Mediastinal Radiotherapy in Surgically Resected Small Cell Lung Cancer.
    Wakeam E; Giuliani M; Leighl NB; Finlayson SRG; Varghese TK; Darling GE
    Ann Thorac Surg; 2017 May; 103(5):1647-1653. PubMed ID: 28267977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical resection should be considered for stage I and II small cell carcinoma of the lung.
    Weksler B; Nason KS; Shende M; Landreneau RJ; Pennathur A
    Ann Thorac Surg; 2012 Sep; 94(3):889-93. PubMed ID: 22429675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of postoperative radiotherapy in multimodality treatment of resected small-cell lung cancer with lymph node metastasis.
    Liu WS; Zhao LJ; Wang S; Gong LL; Liu ZY; Yuan ZY; Wang P
    Eur J Surg Oncol; 2014 Sep; 40(9):1156-62. PubMed ID: 24655801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of postoperative radiotherapy (PORT) in combined small cell lung cancer (C-SCLC).
    Men Y; Luo Y; Zhai Y; Liang J; Feng Q; Chen D; Xiao Z; Zhou Z; Hui Z; Wang L
    Oncotarget; 2017 Jul; 8(30):48922-48929. PubMed ID: 28430661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.
    Mikell JL; Gillespie TW; Hall WA; Nickleach DC; Liu Y; Lipscomb J; Ramalingam SS; Rajpara RS; Force SD; Fernandez FG; Owonikoko TK; Pillai RN; Khuri FR; Curran WJ; Higgins KA
    J Thorac Oncol; 2015 Mar; 10(3):462-71. PubMed ID: 25384064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated?
    Schreiber D; Rineer J; Weedon J; Vongtama D; Wortham A; Kim A; Han P; Choi K; Rotman M
    Cancer; 2010 Mar; 116(5):1350-7. PubMed ID: 20082453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database.
    Corso CD; Rutter CE; Wilson LD; Kim AW; Decker RH; Husain ZA
    J Thorac Oncol; 2015 Jan; 10(1):148-55. PubMed ID: 25325781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer.
    Wang EH; Corso CD; Rutter CE; Park HS; Chen AB; Kim AW; Wilson LD; Decker RH; Yu JB
    J Clin Oncol; 2015 Sep; 33(25):2727-34. PubMed ID: 26101240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of postoperative adjuvant radiotherapy in limited-stage small cell lung cancer: A systematic review and meta-analysis.
    Zhang C; Zhao G; Wu H; Jiang J; Duan W; Fan Z; Wang Z; Wang R
    Radiother Oncol; 2024 Apr; 193():110123. PubMed ID: 38309584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgery.
    Thomas DC; Arnold BN; Rosen JE; Salazar MC; Blasberg JD; Detterbeck FC; Boffa DJ; Kim AW
    Lung Cancer; 2017 Jan; 103():75-81. PubMed ID: 28024700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bolstering the case for lobectomy in stages I, II, and IIIA small-cell lung cancer using the National Cancer Data Base.
    Combs SE; Hancock JG; Boffa DJ; Decker RH; Detterbeck FC; Kim AW
    J Thorac Oncol; 2015 Feb; 10(2):316-23. PubMed ID: 25319182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lobectomy leads to optimal survival in early-stage small cell lung cancer: a retrospective analysis.
    Varlotto JM; Recht A; Flickinger JC; Medford-Davis LN; Dyer AM; DeCamp MM
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):538-46. PubMed ID: 21684554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBase.
    Liu J; Hancock JG; Moreno AC; Wang Z; Boffa DJ; Detterbeck FC; Kim AW
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):596-601. PubMed ID: 25890936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Radiation Therapy in Surgically Resected Limited-Stage Small Cell Lung Carcinoma.
    Kim SK; Manzerova J; Christos P; Wernicke AG; Parashar B
    Lung; 2017 Jun; 195(3):341-346. PubMed ID: 28353115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic Analysis of Lobectomy versus Sublobar Resection in Patients Aged ≥60 Years with Stage Ia Small Cell Lung Cancer].
    Zeng H; Liu Y; Xia X; Li J; He J
    Zhongguo Fei Ai Za Zhi; 2018 Jan; 21(1):8-15. PubMed ID: 29357967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choice of surgical procedure - lobectomy, segmentectomy, or wedge resection - for patients with stage T1-2N0M0 small cell lung cancer: A population-based study.
    Liu Y; Shan L; Shen J; Liu L; Wang J; He J; He Q; Jiang L; Guo M; Chen X; Zeng H; Xia X; Peng G; Liang W; He J
    Thorac Cancer; 2019 Apr; 10(4):593-600. PubMed ID: 30854808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base.
    Robinson CG; Patel AP; Bradley JD; DeWees T; Waqar SN; Morgensztern D; Baggstrom MQ; Govindan R; Bell JM; Guthrie TJ; Colditz GA; Crabtree TD; Kreisel D; Krupnick AS; Patterson GA; Meyers BF; Puri V
    J Clin Oncol; 2015 Mar; 33(8):870-6. PubMed ID: 25667283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery for small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey from 2010 to 2015.
    Xu L; Zhang G; Song S; Zheng Z
    Medicine (Baltimore); 2019 Oct; 98(40):e17214. PubMed ID: 31577711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic biomarker tumor-infiltrating lymphocytes failed to serve as a predictive biomarker for postoperative radiotherapy in completely resected pN2 non-small cell lung cancer: a retrospective analysis.
    Li J; Li L; Wang J; Liu N; Liu H; Xu F; Li M; Yuan S
    Respir Res; 2024 Jun; 25(1):244. PubMed ID: 38886760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.